Scott A. Gerber, PhD
Title(s)
Professor of Molecular and Systems Biology
Professor of Biochemistry and Cell Biology
Additional Titles/Positions/Affiliations
Kenneth E. and Carol L. Weg Distinguished Professor
Director, Cancer Biology & Therapeutics Research Program, NCCC
Associate Director, Quantitative Biomedical Sciences Graduate Program
Department(s)
Molecular and Systems Biology
Biochemistry and Cell Biology
Education
BA, Chemistry, Willamette University
PhD, Analytical Chemistry, University of Washington
Postdoc, Quantitative Proteomics, Harvard Medical School
Programs
Molecular and Cellular Biology Graduate Programs
Dartmouth Cancer Center
Program in Experimental and Molecular Medicine
Quantitative Biomedical Sciences
Websites
http:
Contact Information
One Medical Center Dr.
HB - 7937
Lebanon NH 03756
Office: Rubin 734
Phone: 603.653.3679
Fax: 603.653.9923
Email: scott.a.gerber@dartmouth.edu
Professional Interests
Signal transduction in cell division
Mass spectrometry-based proteomics
Discovery proteomics for thoracic oncology
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Acetylation of WCC is dispensable for the core circadian clock but differentially regulates acute light responses in Neurospora. Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer. P. aeruginosa tRNA-fMet halves secreted in outer membrane vesicles suppress lung inflammation in cystic fibrosis. The USP46 deubiquitylase complex increases Wingless/Wnt signaling strength by stabilizing Arrow/LRP6. An rRNA fragment in extracellular vesicles secreted by human airway epithelial cells increases the fluoroquinolone sensitivity of P. aeruginosa. Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. Proteomics for the Discovery of Clinical Delirium Biomarkers: A Systematic Review of Major Studies. Intraoperative plasma proteomic changes in cardiac surgery: In search of biomarkers of post-operative delirium. Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes. |
|